Definitive Healthcare (NASDAQ:DH) & Dassault Systèmes (OTCMKTS:DASTY) Financial Review

Definitive Healthcare (NASDAQ:DH) and Dassault Systèmes (OTCMKTS:DASTY) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, dividends, risk and institutional ownership.

Insider and Institutional Ownership

98.7% of Definitive Healthcare shares are held by institutional investors. Comparatively, 0.0% of Dassault Systèmes shares are held by institutional investors. 14.8% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Definitive Healthcare and Dassault Systèmes’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-156.65%	0.98%	0.64%
Dassault Systèmes	18.50%	18.53%	10.02%

Risk and Volatility

Definitive Healthcare has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500. Comparatively, Dassault Systèmes has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500.

Earnings and Valuation

This table compares Definitive Healthcare and Dassault Systèmes”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$258.47 million	2.07	-$202.39 million	($1.75)	-2.59
Dassault Systèmes	$6.44 billion	7.35	$1.14 billion	$0.89	39.76

Dassault Systèmes has higher revenue and earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than Dassault Systèmes, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings for Definitive Healthcare and Dassault Systèmes, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	1	7	3	0	2.18
Dassault Systèmes	0	1	1	0	2.50

Definitive Healthcare presently has a consensus target price of $5.81, suggesting a potential upside of 28.03%. Given Definitive Healthcare’s higher probable upside, equities research analysts clearly believe Definitive Healthcare is more favorable than Dassault Systèmes.

Summary

Dassault Systèmes beats Definitive Healthcare on 9 of the 14 factors compared between the two stocks.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

About Dassault Systèmes

Dassault Systèmes SE provides software solutions and services worldwide. It offers SOLIDWORKS provides easy-to-use 2D and 3D product development solutions accessible to any business; CATIA, an engineering and design software for product 3D computer-aided design; GEOVIA for intersection of natural resources, infrastructure, and urban planning; and BIOVIA that develops chemicals, biologics, and materials experiences. The company provides SIMULIA that delivers realistic simulation applications; DELMIA, which enables global industrial operations; 3DVIA that provides 3D space planning solutions; and ENOVIA that enables to plan and track the definition of success for customer. In addition, it offers Centric PLM, a product lifecycle management software solution; 3DEXCITE, a real-time 3D visualization software; NETVIBES, which enables organizations to gather, align, and enrich big data; 3DEXPERIENCE platform that provides organizations a holistic and real-time view of their business activities and ecosystem, as well as connecting people, ideas, data, and solutions together in a single environment; and MEDIDATA, a clinical research study software that provides evidences and insights to pharmaceutical, biotech, medical device, and diagnostic companies, as well as academic researchers. The company distributes its products through direct and indirect sales channels. It primarily serves companies in the transportation and mobility; industrial equipment; aerospace and defense; high-tech; life sciences and healthcare; infrastructure, energy, and materials; home and lifestyle; architecture, engineering, and construction; cities, and public services; consumer packaged goods and retail; marine and offshore; and business services. Dassault Systèmes SE was incorporated in 1981 and is headquartered in Vélizy-Villacoublay, France.